Sonic Healthcare (STU:SAB) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:SAB Sonic Healthcare Ltd STU:SAB
71 GF Score
Price €12.54
GF Value €19.93
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Sonic Healthcare Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

STU:SAB
71GF Score
Sonic Healthcare Ltd STU:SAB
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sonic Healthcare (STU:SAB) Overvalued in 2026?

Based on GuruFocus' analysis, Sonic Healthcare stock appears to be undervalued. The current stock price of €12.54 is trading 37.1% below its estimated GF Value™ of €19.93. GuruFocus considers Sonic Healthcare to be Significantly Undervalued.

Key valuation signals for STU:SAB:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €19.93 vs. price of €12.54 (37.1% below fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the STU:SAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sonic Healthcare Business Description

Address 225 George Street, Level 22, Grosvenor Place, Sydney, NSW, AUS, 2000
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 35% of group revenue in Australia and New Zealand, 25% in the US, and 40% in Europe.
71GF Score

Get the complete analysis for STU:SAB

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.54
Price
€19.93
GF Value